Light-Activated SpyLigation for Precise Protein Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current technologies for controlling protein-protein interactions (PPIs) lack single site precision, bioorthogonality, and irreversibility, making it difficult to achieve precise and spatially controlled biological reactions within complex cellular environments.

Innovation Solution

The development of a versatile protein-protein binding reaction scheme that is highly specific, genetically encoded, phototriggered, and irreversible, utilizing a system of an amino acid, a photolabile cage, and an irreversible conjugation of recombinant proteins, known as Light-Activated SpyLigation (LASL).

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If spontaneous ligation chemistries are used to control PPIs, then reaction specificity is improved, but spatial control and temporal precision are worsened

Engineering Contradiction:
Improvereaction specificityVSAvoidspatial control
Core Design Contradiction:
Measurement precisionVSEase of operation

Solution Approach 1:

The patent applies preliminary action by incorporating photocaged amino acids into proteins during translation, preparing the system in advance for light-triggered activation. The photocaged residues are pre-installed at specific sites, and upon light irradiation, they undergo deprotection to enable controlled PPIs only at the illuminated location and time.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent replaces mechanical or chemical diffusion-based control with optical control. Instead of relying on small molecule diffusion or mechanical mixing to control PPIs, the system uses light irradiation to trigger bond formation, providing precise spatial and temporal control without the limitations of diffusion-based delivery.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Loss of time

If small molecules are used to trigger PPIs, then temporal control is improved, but spatial precision and cellular toxicity are worsened

Engineering Contradiction:
Improvetemporal controlVSAvoidcellular impairment
Core Design Contradiction:
Loss of timeVSObject-affected harmful factors

Solution Approach 1:

The patent substitutes small molecule-based chemical triggering with optical triggering. Light irradiation replaces small molecule addition, eliminating the need for diffusion-based delivery and reducing cellular toxicity. The optical trigger provides both temporal control (when light is applied) and spatial precision (where light is focused).

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent changes the triggering parameter from chemical concentration (small molecule addition) to optical energy input (light irradiation). This parameter change allows for non-invasive control, precise spatial targeting through focused light, and eliminates the cellular impairment associated with small molecule delivery and diffusion.

Inventive Principle:
Principle #35Parameter changes

3Area of stationary object

If photoresponsive protein systems are used for spatial control, then spatial precision is improved, but reaction reversibility and application scope are worsened

Engineering Contradiction:
Improvespatial controlVSAvoidreaction reversibility
Core Design Contradiction:
Area of stationary objectVSStability of the object's composition

Solution Approach 1:

The patent applies preliminary action by incorporating photocaged amino acids into proteins during translation, preparing the system in advance for light-triggered activation. The photocaged residues are pre-installed at specific sites, and upon light irradiation, they undergo deprotection to enable controlled PPIs only at the illuminated location and time.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent changes the bond formation mechanism from reversible non-covalent interactions to irreversible covalent bond formation. The photolysis of caged amino acids generates reactive species that form stable covalent bonds, providing permanent structural changes rather than reversible associations.

Inventive Principle:
Principle #35Parameter changes

4Measurement precision

If genetic code expansion is used for site-specific incorporation, then amino acid specificity is improved, but reaction irreversibility and control precision are worsened

Engineering Contradiction:
Improveamino acid specificityVSAvoidreaction irreversibility
Core Design Contradiction:
Measurement precisionVSStability of the object's composition

Solution Approach 1:

The patent applies preliminary action by incorporating photocaged amino acids into proteins during translation, preparing the system in advance for light-triggered activation. The photocaged residues are pre-installed at specific sites, and upon light irradiation, they undergo deprotection to enable controlled PPIs only at the illuminated location and time.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent replaces spontaneous or diffusion-driven reactions with light-triggered photochemical reactions. The photolysis of caged amino acids generates reactive species that form covalent bonds with high specificity at the illuminated site, providing both irreversibility and precise spatial control.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables spatiotemporal control of protein interactions with high precision and stability, avoiding cellular impairment and ensuring long-term, stable interactions independent of solution conditions.

Implementation Method 1

a caged reactive first protein fragment comprising a first stimulus-responsive cleavable moiety capable of cleaving from the caged reactive first protein fragment, upon application of a predetermined first stimulus

Methodology Applied
Scientific EffectPhotolysis: Photodissociation

Data Source

PatentUS20250129132A1Genetically encoded and exogenously triggered protein-protein ligation
Publication Date: 2025.04.24 UNIV OF WASHINGTON
  • US20250129132A1 patent drawing
  • US20250129132A1 patent drawing
  • US20250129132A1 patent drawing

AI summary

Described herein is a generalizable strategy to rapidly and irreversibly activate protein function with full spatiotemporal control. Through development of an exogenously triggerable self-assembling protein construct, bioactive proteins can be stably reassembled from non-functional split fragment pairs following exposure to a stimulus (e.g., light).